Neuromuscular blockade management in patients with COVID-19

Neuromuscular blockade management in patients with COVID-19

This narrative review evaluates the evidence for using neuromuscular blocking agents (NMBA) in patients being treated for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While large prospective randomized-controlled trials (RCTs) are lacking at this point in time, smaller observational...

Full description

Bibliographic Details
Main Authors: Harold Chaves-Cardona, Vivian Hernandez-Torres, Sean Kiley, Johnathan Renew
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2021-08-01
Series:Korean Journal of Anesthesiology
Subjects:
covid-19
neuromuscular blockade
neuromuscular blocking agents
neuromuscular monitoring
respiratory distress syndrome
sars-cov-2
Online Access:http://ekja.org/upload/pdf/kja-21106.pdf

Internet

http://ekja.org/upload/pdf/kja-21106.pdf

Similar Items